|

Matching placebo in prefilled syringe Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Pipeline

Phase 2: 2

Top Sponsors

  • Connect Biopharm LLC2

Indications

Birmingham, Alabama1 trial

Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)

University of Alabama at Birmingham Lung Health Center

Phase 2

Palo Alto, California1 trial

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.